- Home
- GSBC vs PSTX Comparison
GSBC vs PSTX Comparison
Compare GSBC & PSTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GSBC
- PSTX
- Stock Information
- Founded
- GSBC 1923
- PSTX 2014
- Country
- GSBC United States
- PSTX United States
- Employees
- GSBC N/A
- PSTX N/A
- Industry
- GSBC Major Banks
- PSTX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- GSBC Finance
- PSTX Health Care
- Exchange
- GSBC Nasdaq
- PSTX Nasdaq
- Market Cap
- GSBC 769.0M
- PSTX 909.4M
- IPO Year
- GSBC N/A
- PSTX 2020
- Fundamental
- Price
- GSBC $60.49
- PSTX $9.41
- Analyst Decision
- GSBC Hold
- PSTX Hold
- Analyst Count
- GSBC 2
- PSTX 3
- Target Price
- GSBC $60.00
- PSTX $9.00
- AVG Volume (30 Days)
- GSBC 32.9K
- PSTX 1.3M
- Earning Date
- GSBC 01-21-2025
- PSTX 11-07-2024
- Dividend Yield
- GSBC 2.61%
- PSTX N/A
- EPS Growth
- GSBC N/A
- PSTX N/A
- EPS
- GSBC 5.07
- PSTX N/A
- Revenue
- GSBC $214,729,000.00
- PSTX $150,858,000.00
- Revenue This Year
- GSBC N/A
- PSTX $131.92
- Revenue Next Year
- GSBC $4.21
- PSTX N/A
- P/E Ratio
- GSBC $12.08
- PSTX N/A
- Revenue Growth
- GSBC N/A
- PSTX 203.18
- 52 Week Low
- GSBC $48.19
- PSTX $1.87
- 52 Week High
- GSBC $68.02
- PSTX $9.58
- Technical
- Relative Strength Index (RSI)
- GSBC 44.04
- PSTX 83.90
- Support Level
- GSBC $60.00
- PSTX $9.43
- Resistance Level
- GSBC $66.85
- PSTX $9.52
- Average True Range (ATR)
- GSBC 1.97
- PSTX 0.09
- MACD
- GSBC -0.61
- PSTX -0.23
- Stochastic Oscillator
- GSBC 27.85
- PSTX 43.48
About GSBC Great Southern Bancorp Inc.
Great Southern Bancorp Inc is a bank holding company. It is principally engaged in the business of originating residential and commercial real estate loans, construction loans, commercial business loans, and consumer loans. The bank provides various services such as Business Banking, Merchant Services, Debit and Credit cards, Online Banking, Mobile Banking, VIP Banking, Overdraft Protection, and various other related services.
About PSTX Poseida Therapeutics Inc.
Poseida Therapeutics Inc is a clinical-stage biopharmaceutical company focused on leveraging non-viral gene engineering technologies to create life-saving therapeutics for patients with a high unmet medical need. It has built a pipeline of autologous and allogeneic chimeric antigen receptor T cell, or CAR-T, product candidates, initially focused on the treatment of hematological malignancies and solid tumours.